Today marks the first day of Mitochondrial Disease Awareness Week 💚
Looking back on these moments with my sweet baby, I could’ve never imagined the road we had ahead of us.
I feel like I never appreciated her cries until I could no longer hear them ðŸ˜
Leigh Syndrome is a vicious disease.
I want to spend this week and time sharing moments Salem had, to show how quickly things changed but if I’m being honest, going down memory lane with all of this is SO hard. For MANY reasons.
I can start with the facts.
Leigh Syndrome a rare, inherited neurometabolic disorder that causes the central nervous system to degenerate. It is caused by mutations in genes affecting mitochondrial energy production, either in nuclear DNA or mitochondrial DNA. A common mutation is MT-ATP6 (the mutation I and Salem both possess/possessed 😞💔).
The more we talk, the more research can be done. The more people can become educated. Babies can have lives to where they can thrive and maybe, hopefully, no more babies have to pass away ðŸ˜.
#leighsyndrome #salememmersyn #mitochondrialdisease #trachbabies #gtubebaby #curemito
Leigh Syndrome represents a challenging and heartbreaking diagnosis for families affected by mitochondrial diseases. This rare neurometabolic condition disrupts the central nervous system due to mutations that impair mitochondrial energy production. The MT-ATP6 mutation, in particular, has been shown to play a significant role in the severity of symptoms experienced by patients, including developmental regression, muscle weakness, and respiratory difficulties. The progression of Leigh Syndrome can be rapid and devastating, often starting in infancy or early childhood. Families face numerous obstacles, from managing complex medical needs like tracheostomy and gastrostomy tubes to coping with the emotional toll of watching a loved one’s health decline. Unfortunately, treatment options remain limited, with current care focusing primarily on symptom management rather than a cure. Raising awareness during Mitochondrial Disease Awareness Week is crucial to drive research funding and improve diagnostic tools. By educating the public and healthcare professionals about Leigh Syndrome and other mitochondrial disorders, we can promote earlier detection and intervention. Genetic counseling and advanced genomic testing allow for better understanding of the specific mutations involved, which may lead to more targeted therapies in the future. Community support also plays a vital role in helping families navigate the challenges posed by mitochondrial diseases. Sharing personal stories helps reduce isolation and builds solidarity among affected individuals. Advocacy efforts are ongoing to increase government and private sector investment in mitochondrial research, which may one day lead to breakthroughs offering hope for children diagnosed with Leigh Syndrome. In addition, focusing on newborn screening and early identification can potentially reduce fatalities and improve quality of life. Scientific advancements, such as mitochondrial replacement therapy and gene editing, hold promise but require further clinical trials and ethical considerations. As awareness spreads, collaboration among researchers, clinicians, and families will become stronger. This unity boosts the likelihood that future generations of babies with mitochondrial disorders like Leigh Syndrome can experience longer, healthier lives. Every conversation contributes to this goal, making awareness weeks not only a time of reflection but a catalyst for hope and change.